Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis (Q36077514)

12 August 2017

Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis (English)

1 reference

12 August 2017

0 references

Daniel B Drachman

1

1 reference

12 August 2017

Robert N Adams

2

1 reference

12 August 2017

Rong Hu

3

1 reference

12 August 2017

Richard J Jones

4

1 reference

12 August 2017

Robert A Brodsky

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Annals of the New York Academy of Sciences

12 August 2017

1 reference

12 August 2017

1132

1 reference

12 August 2017

305-314

1 reference

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Host-reactive CD8+ memory stem cells in graft-versus-host disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

High-dose therapy for autoimmune neurologic diseases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Quantification of T cell receptor rearrangement excision circles to estimate thymic function: an important new tool for endocrine-immune physiology.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Assessment of aldehyde dehydrogenase in viable cells.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Treatment of ongoing experimental myasthenia gravis with short term high dose cyclophosphamide.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

4-Hydroperoxycyclophosphamide inhibits proliferation by human granulocyte-macrophage colony-forming cells (GM-CFC) but spares more primitive progenitor cells.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Thymic function in severely immunodeficient HIV type 1-infected patients receiving stable and effective antiretroviral therapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

High-dose cyclophosphamide as salvage therapy for severe aplastic anemia

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Treatment of refractory myasthenia: "rebooting" with high-dose cyclophosphamide

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

High-dose cyclophosphamide for refractory autoimmune hemolytic anemia.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

Combined short-term immunotherapy for experimental autoimmune myasthenia gravis

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390145

High-dose cyclophosphamide in aplastic anaemia

23 September 2018

1 reference

12 December 2020

1 reference

12 December 2020

Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice

1 reference

12 December 2020

Karnofsky performance status revisited: reliability, validity, and guidelines

1 reference

12 December 2020

1 reference

12 December 2020

Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease

1 reference

12 December 2020

Changes in thymic function with age and during the treatment of HIV infection

1 reference

12 December 2020

Identifiers

DOI

10.1196/ANNALS.1405.033

1 reference

12 August 2017

1 reference

12 August 2017

1 reference